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Abstract 22 
As a model of extreme conditions, eight healthy women, part of a 40-member Nepal mountain-23 
climbing expedition, were monitored for dynamic endocrine adaptations.  Endocrine 24 
measurements were made at frequent intervals over a 6-10 hours period at four altitudes: 450 m, 25 
4800 m (Base Camp), 6050 m and again at 4800 m (on descent) after an acclimatization period 26 
(4800 mA).  Quantified hormones were growth hormone (GH), prolactin (PROL), Cortisol (Cort), 27 
Thyroid-stimulating hormone (TSH), and free thyroxine.  These hormones are important to the 28 
anabolic/catabolic balance of the body, and are vital to growth, homeostasis, hypothalamic 29 
inhibition, regulation of stress and metabolism. A key secondary question was the degree to which 30 
acclimatization can stabilize hormonal disruption.  Based upon statistical false discovery rates, the 31 
present analyses unveil marked adaptive changes in the thyroid axis at the level of pulsatile 32 
secretion of the pituitary hormone TSH and its downstream product, free thyroxine; strong effects 33 
upon the mass of GH, TSH, Cortisol and PROL secretion per burst; and prominent pulsatile 34 
frequency disruption and recovery for PROL and cortisol.  Since pulsatility changes reflect de 35 
facto perturbations in hypothalamo-pituitary control mechanisms, the present data introduce the 36 
concept of both frequency and amplitude-dependent adaptive control of brain-pituitary 37 
neuroendocrine signals under conditions of extreme altitude exertion and exposure. 38 
 39 
Abstract word count: 207    40 
Keywords: Growth hormone, prolactin, cortisol, thyroid stimulating hormone, free thyroxine, 41 
altitude, hypobaric hypoxia 42 
 43 
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1. Introduction 44 
Stress-related successful adaptations or failures of critical endocrine systems are contributors to 45 
health or morbidity and mortality across diverse ethnic, age, occupational and health groups in 46 
both sexes.  For example, physiological adaptations of the hypothalamic-pituitary-adrenal axis 47 
(HPA) to major internal and external stressors are fundamental to maintain homeostasis and 48 
attendant health and longevity.  However, major stressors especially when combined are not ethical 49 
to apply to normal individuals.  One context of massive and multifactorial stress is ascent to high 50 
altitude under combined stresses of hypoxia, heavy physical exertion, psychological stress, sleep 51 
deprivation, cold exposure and dietary changes.  The acute hypoxic setting may per se be 52 
deleterious both acutely and in the long-term. Catabolic manifestations of weight loss and 53 
sarcopenia are frequent in hypoxemic patients with COPD (14), or otherwise healthy subjects 54 
exposed to high altitude (6, 7, 26).  Likewise, sustained heavy physical exertion is strongly 55 
catabolic.  In mountaineering, hypoxia and exhaustion are likely exacerbated by psychological 56 
stress, sleep deprivation, high variation in temperature and high nutritional demand.  In contrast, 57 
physical exertion drives the growth hormone axis which is anabolic, and cold exposure drives the 58 
thyroid axis, also anabolic. How the aggregate of these factors affect endocrine systems is 59 
unknown.   60 
      In principle, disruption of endocrine regulation could mediate high-altitude sickness and might 61 
even explain the condition of high-altitude deterioration, a severe catabolic state ultimately leading 62 
to death. Few studies have investigated changes in hormone secretion at high altitudes.  Thyroid 63 
hormones were found to increase, but thyroid-stimulating hormone (TSH) was preserved in single-64 
sample studies at around 3500 to 4300 m (1, 2). In other studies, cortisol concentrations rose during 65 
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acute hypoxic exposure (21, 22). Changes reported in other endocrine systems have been 66 
contradictory (3, 13, 16, 21).  67 
      A large observational study of the authors, performed in the same expedition with both male 68 
and female subjects at various altitudes up to 7000 m under standardized conditions revealed that 69 
adrenal, thyroid and gonadal axes are affected by increasing altitude. Adrenal axis and prolactin 70 
were activated and thyroid axis suppressed at very high altitude >4.800 m. Acclimatisation at 4800 71 
m led to normalization of adrenal but not of thyroid axes (27). However, this and none of the 72 
previous studies counted for physiological pulse patterns of pituitary and adrenal hormone 73 
secretion, which constitutes an integral part of hormonal regulation (25). 74 
      To assess the pathophysiologic impact of progressive altitude ascent on hypothalamo-pituitary 75 
function in a more comprehensive manner, we undertook systematic analysis of the pulsatile 76 
patterns of growth hormone (anabolic), prolactin (hypothalamic dopamine monitor), cortisol 77 
(catabolic), TSH and free thyroxine (anabolic) secretion in 8 women across successive altitudes 78 
from 450 m to a very high altitude of 6050 m. In addition, we tested the hypothesis that 79 
acclimatization to 4800 m on the descent leads to a stabilization of endocrine changes.   80 
 81 
2. Materials and Methods 82 
2.1 Course of the expedition and participants 83 
The medical research expedition involved Mount Himlung Himal (7126 m) in Nepal.  Blood 84 
sampling and comprehensive cardiorespiratory assessment were performed at four altitudes: 450 85 
m (baseline); 4800 m (Base Camp 1) on Day 7; 6050 m (Camp 2) on Day 13; and, again at 4800 86 
m on Day 19 (or 20) after an acclimatization period (4800 mA). The ascent protocol was in 87 
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accordance with standard practices, so to allow for adequate acclimatization and to minimize the 88 
risk of severe altitude illness. 89 
      Eight healthy female subjects who were part of this 40-member medical research expedition 90 
volunteered for repeated blood sampling.  All individuals were from a lowland environment, but 91 
had basic mountaineering experience. None of the female subjects had any neurologic, cardiac or 92 
respiratory disease, diabetes mellitus type I or II, or the need for any regular medication, 93 
particularly thyroid hormones, corticosteroids and other medication which could possibly affect 94 
hormone analysis. Comprehensive details of the protocol and subject recruitment are published 95 
elsewhere (4, 17, 27). 96 
     For each of the eight women, growth hormone (GH), prolactin (PROL), Cortisol (Cort), 97 
Thyroid stimulating hormone (TSH) and free (unbound) thyroxine (fT4) were assayed at each 98 
study site over approximately six hr of frequent (10-20 min intervals) blood sampling.  99 
 100 
2.2 Experimental Protocol 101 
At each of the four altitudes, blood sampling was performed at a targeted frequency of every 10-102 
20 min for a targeted interval of six hours (10 min for first two hours; 20 min for the last four 103 
hours).  Meeting these targets varied slightly from individual to individual and within individual 104 
across different altitudes due to the complexity and changing nature of the environment.  The 105 
strength of observing the same individuals at the four altitudes is that paired comparisons can be 106 
achieved, allowing for greater statistical power and precision. 107 
     Blood samples of 1.2 ml were withdrawn from a peripheral venous needle. All blood samples 108 
were centrifuged immediately for 10 min at 2000 g (EBA 20, Hettich AG, Bäch, Switzerland). 109 
Aliquots were frozen to -40° to -60°C on-site and kept frozen at -80°C until analysis. The assays 110 
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were as follows: (1) GH was measured on a IMMULITE 2000 XPI (Siemens, Erlangen, Germany) 111 
using a solid-phase, two-site chemiluminescent immunometric assay (IMMULITE 2000 Growth 112 
Hormone, Siemens, Erlangen, Germany) with normal values <7.0 ug/l; (2) prolactin was quantified 113 
using a homogeneous, sandwich chemiluminescent immunoassay (LH FLEX reagent, Siemens, 114 
Erlangen, Germany) on a Dimension Vista System (Siemens, Erlangen, Germany) with normal 115 
values 2.2 – 28 ug/l; (3) cortisol was assessed by competitive immunoassay (Advia Centaur 116 
Cortisol Assay, Siemens, Erlangen, Germany). Detection range 13.80 – 2069 nmol/l and normal 117 
values 140-700 nmol/l; (4) TSH was measured by a homogeneous, sandwich chemiluminescent 118 
immunoassay (TSH FLEX reagent and Dimension Vista System, Siemens, Erlangen, Germany) 119 
with normal values of 0.4-4.0 mlU/l; and, (5) fT4 was assayed via a homogeneous, sequential 120 
chemiluminescent immunoassay (fT4 FLEX reagent, Siemens, Erlangen, Germany) using 121 
Dimension Vista System (Siemens, Erlangen, Germany) with normal values of 9.9-19.3 pmol/l. 122 
 123 
2.3Statistical Modeling 124 
2.3.1 Hormone dynamics 125 
Changes in physiological hormone regulation are monitored most often at the concentration level, 126 
but are mediated by changes at the levels of unobserved underlying secretion rates and kinetics, 127 
here termed hormone dynamics.  Two of the authors (D.M. Keenan, J.D. Veldhuis) have developed 128 
over the past 20 years methods to recover hormone secretion and elimination rates from sequential 129 
measurements of time-varying concentrations (15, 25).   For each hormone and each subject, the 130 
basic model from which summary statistics for hormone dynamics can be calculated is as follows:  131 
     First, for each hormone (per subject), there are m (unobserved) secretory pulse times to be 132 
estimated: 133 
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                                     Τ = (Τ( ), Τ( ), … , Τ( ))     (m also unknown) 134 
The estimated length of times between pulse times, i.e., interpulse intervals (IPI), for each person, 135 
hormone and altitude were modeled as a Weibull renewal processes (the IPI’s are IID Weibull 136 
random variables).  There are two pulse-related parameters: pulse frequency λ (approximately, the 137 
reciprocal of the Weibull mean) and a pulse regularity parameter γ.  The regularity parameter is 1 138 
for a Poisson process, and increases as the IPI’s become more regular (the coefficient of variation 139 
is inversely related to γ).  Starting at pulse time T( ), an accumulated mass  M( ) of hormone is 140 
released: 141 
                                     M( ) = (η + η × (Τ( ) − Τ( )) + A( )                                       (1) 142 
which is assumed to be a linear function of the IPI plus a random effect.  The random effect allows 143 
for desensitization and inherent biological variation, modeled as IID N(0, σ ).  The mass is 144 
released at a time-varying rate (mass per unit distribution value per unit time): 145 
                           ψ(s) ∝ s ( ) ( ) e ( ) ( ) , s ≥ 0   (a normalized rate of release)            (2) 146 
given as a three-parameter Gamma density.  The resulting secretion rate is then the sum of two 147 
components: a (constant) 𝛽  basal secretion rate and the pulsatile secretion rate: 148 
                       𝑍(𝑠) = 𝛽 + ∑ 𝑀( )𝜓 𝑠 − Τ( )( )            (Secretion Rate at time s)          (3) 149 
     A biexponential elimination rate is necessary to properly model the kinetics; specifically, a 150 
single exponential decay results in an overestimation of the secretion (15).  The two fractional 151 
elimination rates are a fast rate 𝛼( ), which captures the rapid effects of diffusion and advection, 152 
and a slow rate 𝛼( ), which describes the removal from the blood.  The result of the two processes, 153 
secretion and kinetics, are the time-evolving (true) hormone concentrations:  154 
 155 
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𝑋(𝑡) = 𝑎𝑒 ( ) + (1 − 𝑎)𝑒 ( ) + 𝑎𝑒 ( )( ) + (1 − 𝑎)𝑒 ( )( )  𝑍(𝑠)𝑑𝑠     (4) 156 
 with that which is observed by frequent blood sampling and hormone assay being: 157 
        𝑌 = 𝑋(𝑡 ) + 𝜀 , 𝑖 = 1, … , 𝑛      (the observed concentrations)                                     (5) 158 
where the 𝜀  ‘s are IID 𝑁(0, 𝜎 ) and denote general randomness and measurement error. 159 
Thus, for each subject and each of the five hormones, there is a parameter space: 160                  𝜃 = (𝛼( ), 𝛼( ), 𝛽 , 𝛽( ), 𝛽( ), 𝛽 , 𝜂 , 𝜂 , 𝜎 , 𝜎 )                                                  (6) 161 
Estimates of the components of the parameter set produce ten summary statistics.  The first four 162 
statistics, are “somewhat independent” of one another – this will be important in an interpretation 163 
of the False Discovery Rate (FDR) adjustment for multiple P-values: 164 
(1) Mass Per Pulse (MPP); (2) Pulse Frequency (scaled to #/24 hrs); (3) Total Secretion (basal plus 165 
pulsatile) (scaled to 24 hrs); (4) Basal Secretion.  The remaining six statistics are: (5) Total 166 
Pulsatile Secretion (scaled to 24 hrs); (6) Fractional Basal Secretion (scaled to 24 hrs); (7) Pulse 167 
Regularity; (8) Mode of burst-like Release; (9) Fast Half-Life; (10) Slow Half-Life. 168 
 169 
2.3.2 Statistical hypotheses 170 
   We focus on Six Hypothesis Groups (the first two are the primary ones).  For each Hypothesis 171 
Group there are 10 summary variables for each of the five hormones (10 𝑥 5 =)50 potential 172 
hypothesis tests. Moreover, in a strict hypothesis-testing context, statistics are formulated as the 173 
alternate hypotheses.  For example, Hypothesis Group 1 is that 4800 m acclimatization results in 174 
a reduction in the basic summary variables, in comparison to 4800 m. (The reduction being back 175 
towards that of the Baseline.) The resulting P-values will be the evidence that this is true, i.e., that 176 
the complement (Acclimatization not resulting in a reduction) is false.     177 
 178 
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H1: 4800 m vs (or, more precisely, >) 4800 m Acclimatized (i.e., acclimatization results in a 179 
reduction in the key summary statistics). 180 
H2: 6050 m vs (>) 4800 m (i.e., the increased altitude causes an increase in the summary statistics). 181 
H3: 4800 m vs (>) 450 m (i.e., the increased altitude causes an increase in the summary statistics 182 
compared with Baseline). 183 
H4: 4800 m Acclimatization vs (>) 450 m (i.e., the increased altitude, even after acclimatization, 184 
causes an increase in the summary statistics compared with Baseline). 185 
H5: 6050 m vs (>) 450 m (i.e., the increased altitude causes an increase in the summary statistics 186 
compared with Baseline). 187 
H6: 6050 m vs (>) 450 m Acclimatization (i.e., the increased altitude causes an increase in the 188 
summary statistics compared with 4800 m Acclimatization). 189 
 190 
As stated above, there 10 summary variables for each of the five hormones (10 x 5 =191 50 variables), with each potentially part of each of six hypotheses (𝐇𝟏 − 𝐇𝟔).  How to test 192 
multiple hypotheses has always been a difficult statistical question.  The one mainstay, though, 193 
has always been that hypotheses that were precisely formulated prior to the observation of the 194 
data should not require an additional allowance of randomness to account for their prior non-195 
selection.  This allowance has historically taken the form of multiple comparisons, Studentized 196 
range, Bonferroni adjustments and, most importantly for modern statistics, the False Discovery 197 
Rate (FDR).  We state this, inasmuch as our four key summary statistics and our two most 198 
important hypothesis groups (H1 and H2), for the five hormones, were obvious prior hypotheses.  199 
It is not as if they were devised based upon the observed data, and that should therefore be 200 
considered in evaluating their P-values (Figure 4, described below). 201 
Downloaded from www.physiology.org/journal/ajpendo at Univ Bern Hosp (161.062.252.040) on December 12, 2019.
 
 
  - 10 - 
3. Results  202 
      In the present study, eight women were evaluated over 6-10 hr periods with blood sampling 203 
every 10-20 min, at four altitudes: base camp (450m), 4800m, 6050m and again at 4800m (on 204 
descent) with a period for acclimatization. Note that in the figures, 4800 mA is placed next to 4800 205 
m for ease of comparison, even though chronologically realized after 6050 m on the descent.  The 206 
focus of the present study is on changes in anabolic-catabolic balance under extreme altitude.  Five 207 
hormones were measured from each blood sampling: GH, PROL, Cortisol, TSH and fT4.   Because 208 
of the extreme conditions, the length of blood sampling for different individuals at a given altitude 209 
and the same individual at different altitudes varied by necessity.  Hence, to place summary 210 
statistics on comparable scales, measures that involved time were scaled to their corresponding 211 
24-hr values (e.g., pulse frequency, and basal and total pulsatile secretion). 212 
      In Figure 1, all of the blood-sampled concentrations, across the four altitudes (columns) and 213 
the five hormones (rows), are displayed for the eight subjects.  The concentration scale for any one 214 
hormone is the same across altitudes, for ease of comparison.  Prominent pulsatility is evident in 215 
all hormones.  The general similarity across altitude reflects the fundamental difficulty in the 216 
detection of changes in the dynamics.  Because each individual is followed across the four 217 
altitudes, one can remove individual variation via differencing between two altitudes (i.e., pairing). 218 
Without doing this it would be difficult to identify differences across altitude.   219 
      Our two most important hypotheses (H1-H2) concern, respectively, acclimatization (at 220 
4800m) and the final increase in altitude from 4800m to 6050m.  To test these and the other 221 
hypotheses, one must recover, from the concentrations, the unobserved hormonal secretions, 222 
removing the effects of hormone elimination.  In Figure 2a the analytically recovered (estimated) 223 
time-varying hormone secretion rates are displayed, the result of the statistical deconvolution 224 
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methods described in Methods.  One visual consequence is that changes in dynamical regulation 225 
are not easily detected in one-dimensional plots, except for the rather dramatic drop in GH 226 
secretory-burst size (mass) at 4800 m after acclimatization.   227 
     Four key outcome statistics are: Mass Per Pulse (MPP), Pulse Frequency (scaled to 24 hr), 228 
Total Secretion (scaled to 24 hr) and the Basal Secretion (scaled to 24 hr).   In Figure 2b, these 229 
four summary statistics (mean (dashed line), median (solid line)) are displayed, subject by subject 230 
(different colors), across the different altitudes.  Because there are differences in the units of 231 
measurement for each hormone, for comparison purposes, we have scaled each of the four statistics 232 
by their maximum (across subjects).  An overall pattern is visually revealed suggesting the effects 233 
of acclimatization, especially in Mass Per Pulse (MPP) in each of the five hormones, the left-most 234 
subplot. MPP values, for each hormone, are significantly increased at 4800m and 6050m, with 235 
those at 4800mA (acclimatization) brought back towards baseline (450m).  This is borne out in the 236 
hypothesis testing displayed in Figure 5, discussed below, suggesting that acclimatization can 237 
stabilize (at least certain aspects of) hormonal disruption due extreme altitude. 238 
       In Figures 3-4, a more precise and detailed display of the above four principal summary 239 
statistics is presented, with certain novel and significant patterns visually highlighted for all five 240 
hormones and all eight subjects.  In each subplot (a-b) of Figures 3-4, there are two columns.  The 241 
left column displays (asterisks) all of the values, for the eight subjects, of the four principal 242 
summary statistics, hence allowing for an interpretation of the distributions. Visual comparisons 243 
of baseline (450 m), 4800 m and 4800 mA are quite dramatic with respect to distinct hormone 244 
changes in MPP, pulse frequency and total and basal secretion.  For most hormones, MPP goes up 245 
and then down (with acclimatization), becoming potentially lower than baseline (Figure 3a).  246 
Pulse frequency (except for GH and fT4) does the reverse (Figure 3b), going down in the transition 247 
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from 450 m to 4800 m and then rising dramatically at 6050 m.  At 4800 m, pulse frequency is 248 
similar to that at 6050 m.  The data indicate a physiological effect of the 450 m to 4800 m transition 249 
for both secretory burst mass and number, which is distinct to hormone type. The rise in MPP 250 
and/or frequency contributes to an increase in overall pulsatile secretion (the product of burst mass 251 
and frequency), which with basal secretion sums to total secretion.   252 
    The right column of each subplot (a-b) of Figure 3-4 depicts intraindividual hormone 253 
differences corresponding to each hypothesis (1-6).  It is these paired values which are the basis 254 
for the hypothesis testing (Figure 5).  For some summary statistics, the appropriate hypothesis to 255 
test would be to one side (e.g., an increase) as opposed to the other direction (e.g., a decrease).  For 256 
others it would be opposite.  To account for this, we have calculated the P-value in both one-sided 257 
directions and taken the minimum of the two; if a two-sided test were deemed appropriate, it would 258 
be double this value. 259 
       For Total Secretion (Figure 4a), the most dramatic changes are in the thyroid axis.  Total TSH 260 
and fT4 secretion increase significantly with altitude, with a return to baseline values (450 m) after 261 
acclimatization at 4800 m. On the other hand, GH, PROL and Cortisol’s total secretion at 450 m, 262 
4800 m and 6050 m are not so different, although values at 4800 mA are reduced.  Basal (non-263 
pulsatile) (Figure 4b) similarly has an intriguing pattern.  Basal secretion rates at baseline 450 m 264 
and at 4800 mA are similar, whereas values decrease at altitudes of 4800 m and 6050 m.  This 265 
occurs concomitantly with a rise in pulsatile secretion [Figure 7a-b].        266 
     Figure 5 provides P values for each hormone and each hypothesis.  In Figure 5a, for the four 267 
key summary variables, we plot the P-values over the six hypotheses, quantifying what was 268 
summarized above concerning Figures 3-4.  The testing was done using a t-test (7 degrees of 269 
freedom (df)).  For Hypothesis 1 (comparing 4800 m to 4800 mA), all five hormones show highly 270 
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significant decreases in MPP (P<10-6, for each).  Cortisol pulse frequency increases are highly 271 
significant for 6050 m compared to 450 m and 4800 m altitudes (). All hormones except PROL 272 
significantly decreased their Basal Secretion due to acclimatization (P<.05).  A striking additional 273 
outcome is the significance of fT4 Total Secretion comparisons for all six Hypotheses (P<10-4, in 274 
all but H2).  TSH Total Secretion comparisons are highly significant for the three elevations (4800 275 
m, 6050 m, 4800 mA) compared to baseline (450 m) (P<10-4, for each). 276 
        Thus, hormone- and altitude-specific adaptations in hypothalamo-pituitary regulation were 277 
inferable in the women climbers studied here. Foremost were highly significant changes in the 278 
burst-like mode of intermittent fT4 and TSH secretion over time. For both hormones in the 279 
thyroidal axis, analytically estimated pulse frequency was altitude-independent, whereas the mass 280 
of hormone released per pulse and the time-invariant basal secretion rate increased significantly 281 
after ascension from 450 m to 4800 m, and analogously at the extreme elevation of 6050 m 282 
compared with 450 m. Both secretion features decreased in magnitude with acclimatization (4800 283 
mA) compared with 4800 m).  Elevated thyroid hormone output at high altitude is consistent with 284 
the cold stress so anticipated, and the whole-body adaptation to the same.  Our data show further 285 
that the pituitary and hypothalamus are involved, since both TSH and fT4 rose, framing the 286 
consideration that feedback upon the hypothalamus and pituitary gland is muted under these 287 
conditions. Otherwise, the rise in fT4 of purely thyroidal origin would be expected to quench TSH 288 
release, which did not occur (22).  289 
        Figure 5b displays a False Discovery Rate (FDR) plot (six subplots) for each of the six 290 
Hypothesis Groups (H1-H6) at the 𝛼=.05 level.  In each, the 20 P-values: 20=4 (statistics) x 5 291 
(hormones) are plotted on a log scale with differing symbols and colors.   The importance of Figure 292 
5b is the additional reassurance of the statistical significance of the results in Figure 5a, described 293 
Downloaded from www.physiology.org/journal/ajpendo at Univ Bern Hosp (161.062.252.040) on December 12, 2019.
 
 
  - 14 - 
above.   Moreover, when one has hypotheses specified a priori, as with our four primary summary 294 
statistics, a traditional comparison to 𝑔𝑖𝑣𝑒𝑛 𝛼 (e. g. , .05) level of significance is justified.  The 295 
merit of FDR is in the case where hypotheses may have been selected after the data has been 296 
obtained. 297 
       Thus, for the test of Acclimatization (Hypothesis 1), all hormones except fT4 exhibit a 298 
decrease in pulsatile secretion.  PROL shows a dramatic decrease in the mode of burst-like 299 
secretion (faster release).  Both thyroid hormones, TSH and fT4, exhibit increases in basal 300 
secretion when altitudes 4800 m, 4800 mA and 6050 m are compared with 450 m (Hypotheses 3-301 
5).  Other variables are different for one altitude comparison, but not for others, and we have not 302 
elaborated on those occurrences.  In Figure 5c, we make the same assessments as in Figure 5a, 303 
but use a sign-test rather than a t-test.  From Figures 3-4, one can see that some of the paired 304 
difference distributions have occasional values larger than the rest.  The sign test will remove any 305 
undue influence of such extreme values. The results of significance (i.e., P-values) are quite similar 306 
to those of Figure 5a (and hence to Figure 5b).  307 
       Figures 6-7 present the remaining six outcome variables.  The format is the same as in Figures 308 
3-5.  The six summary statistics are Total Pulsatile Secretion, Fractional Basal of Total Secretion, 309 
pulse regularity (a Weibull distribution parameter), mode of secretory release (for the waveform 310 𝜓) and, the fast and slow half-lives of elimination.  For statistical evaluations of these latter six 311 
outcomes variables, Figure 7a depicts P-values using a t-test (7 df) over the six hypotheses.  For 312 
Hypothesis 1(Acclimitization at 4800 m), both total pulsatile secretion and the fraction of basal to 313 
total secretion are highly significant (P<10-3) for GH, PROL, Cort and TSH, with fT4 being just 314 
above the P=.05 level. In Figure 7b, a FDR plot is given for each of the six Hypothesis Groups 315 
(H1-H6) at the 𝛼=.05 level.  Its importance is that it substantiates the above mentioned highly 316 
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significant Hypothesis 1 results.  Figure 7c represents statistical inferences using a sign-test rather 317 
than a t-test.  In all 3 assessments, results are quite similar. 318 
 319 
4. Discussion 320 
       Hypothalamo-pituitary dependent adaptations in endocrine regulation due to extreme altitude 321 
conditions were evaluated in 8 women, by sampling blood every 10-20 min over a 6-10 hr period 322 
at four altitudes (450 m, 4800 m, 4800 m Acclimatization, and 6050 m).  Five representative 323 
anabolic, catabolic, and hypothalamically restrained (PROL) hormones: GH, PROL, Cort, TSH 324 
and fT4, were assayed in each sample of each hormone time series to quantify hormonal pulse 325 
amplitude and frequency (25).   Because the same individuals were evaluated at each altitude, and 326 
the outcome statistics were summarized at each altitude, paired comparisons were made for each 327 
subject and altitude.  Other studies (27) have been conducted in which changes in the levels of the 328 
reproductive hormones (LH, testosterone) were the focus.  One difficulty with such studies is the 329 
individual non-synchronous differences (per female participant) in menstrual cycle phases.  330 
Consequently, in the present investigation, the focus is on anabolic-catabolic hormone balance (or 331 
imbalance) under extreme altitude conditions. Data in this unique setting are sparse, due to the 332 
substantial challenges earlier in obtaining frequently sampled hormone time series under the severe 333 
physical and psychological stresses of mountaineering. 334 
       Foremost of the changes in dynamical response to extreme altitude were the highly significant 335 
changes in the burst-like mode of intermittent fT4 and TSH secretion over time.  Secondary major 336 
outcomes of the analysis were changes in hypothalamically regulated pulse frequencies of PROL 337 
and Cort.  Both pulse frequencies decreased after climbing from 450 m (baseline) to 4800 m, and 338 
then increased with acclimatization at 4800 m, thus returning toward baseline levels.  After the 339 
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extreme condition change from 4800 m to 6050 m, both pulse frequencies increased further.  A 340 
change in pituitary-target gland pulse frequencies is taken as prima facie evidence of hypothalamic 341 
adaptations, inasmuch as both the pituitary gland and the adrenal gland are devoid of intrinsic 342 
pulsatility when study ex vivo or after hypothalamic disconnection in vivo (10-12, 19, 24). 343 
       Another major finding was that the mass of hormone secreted per burst for all four of PROL, 344 
Cort, TSH and GH fell significantly during acclimatization at 4800 m (Hypothesis 1), as did the 345 
fraction of basal to total secretion. Since pulsatile pituitary-target organ hormone release in each 346 
of these endocrine axes is modulated by hypothalamic neurotransmitter drive (GH, TSH, Cort) or 347 
restraint (PRL under dopaminergic inhibition), the present data provide the first clear evidence that 348 
exertion, hypoxia, nutrition, stress and fatigue associated variously with strenuous high-altitude 349 
ascent strongly control the brain and pituitary gland in healthy human beings.  350 
       Adaptations in pituitary-hormone pulse frequency are particularly notable mechanistically. 351 
This is because the pituitary gland per se acquires its timing (frequency and spacing) of secretory 352 
bursts from hypothalamic signals (10-12, 19, 24) rather than from intrinsic pulsatility of pituitary 353 
tissue. Thus, a change in hormone pulse number denotes a de facto change in hypothalamic 354 
neurotransmitter regulation of the pituitary gland. Notably, both prolactin and cortisol pulse 355 
frequencies slowed significantly at 4800 m compared with 450 m. With continued adaptation to 356 
higher altitude including 6800 m, both pulse frequencies rose again. These patterns strongly 357 
support hypothalamic neurotransmitter adaptations, since prolactin is under dopamine restraint 358 
primarily, where cortisol is under noradrenergic stimulation via the peptides ACTH-releasing 359 
factor (CRH) and vasopressin (AVP) (18). There is evidence for even more complex multifactorial 360 
regulation of prolactin and ACTH-cortisol pulse timing, via neurotransmitters such as GABA, 361 
NMDA, serotonin, acetylcholine among others. Whatever the dominant prolactin and ACTH pulse 362 
Downloaded from www.physiology.org/journal/ajpendo at Univ Bern Hosp (161.062.252.040) on December 12, 2019.
 
 
  - 17 - 
onset-determining pathway in humans, the presently observed pulse slowing for prolactin and 363 
cortisol point to altitude/exertion effects on such pulse-regulating inputs to the pituitary. However, 364 
adaptive recovery of pulse frequency at sustained high altitude provides important evidence that 365 
pulse slowing is not permanent.  366 
      Changes in pituitary-hormone secretory pulse size (burst mass, or serum hormone pulse height) 367 
are jointly determined by pulse frequency (higher frequencies yielding smaller pulses) and by 368 
hypothalamic secretagogues or inhibitors controlling pituitary secretion directly. This dogma is 369 
well articulated for the GH axis, where in both GHRH and ghrelin (secretogogues) augment, 370 
whereas somatostatin suppresses the size of GH pulses (11).  Moreover, systemic blood-borne 371 
hormones and metabolites further enhance or diminish pituitary responses to brain signals. 372 
Accordingly, pulse size is the result of four major regulatory interactions: hypothalamic 373 
neurotransmitter amount and type (stimulation or inhibition), and timing (frequency), and intrinsic 374 
pituitary responsiveness as modified by blood-borne signals (e.g., free fatty acids as a circulating 375 
negative effector of GH pulse size). Thus, interpretation of pituitary-hormones burst-mass changes 376 
is more complicated. For example, the smaller size of pulses of prolactin, cortisol, TSH and GH 377 
during adaptation to 4800 m would plausibility reflect greater dopamine inhibition (prolactin, TSH 378 
and GH), lesser noradrenergic drive (Cort and GH), more hypothalamic somatostatin inhibition 379 
(prolactin, TSH and GH, and to a lesser degree, ACTH/Cort), and/or higher IGF-F restraint (GH) 380 
(10-12, 19, 23, 24).  381 
       Whatever the final mechanisms eventually proven in further experimental models, the present 382 
pulsatility data allow for the first time a clear inference that combined hypothalamic-pituitary 383 
mechanisms mediate the prominent endocrine changes associated with high altitude exposure. 384 
Detailed neuropharmacological and neuroendocrine interventional experiments will be needed to 385 
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elucidate the molecular causes for the observed changes in all of TSH (frequency and amplitude), 386 
as well as prolactin, Cort and GH (primarily amplitude). 387 
      The control of low basal (non-pulsatile) hormone secretion is not well understood (9). A 388 
plausible and testable hypothesis is that sustained neurotransmitter drive serves to increase 389 
intracellular pituitary hormone accumulation, and thus secondary elevate interpulse release as 390 
basal secretion.  This assumes that basal secretion is due to constitutive unregulated hormone 391 
release, as distinct from pulsatile secretagogue-induced burst-like release of predocked secretory 392 
granules (25). 393 
       These findings also raise the question as to whether the hormonal changes are linked to the 394 
cardiorespiratory and metabolic changes which can be found in hypobaric hypoxia (18). In a 395 
previous paper (27) it was demonstrated that total hormone concentrations are closely linked with 396 
altitude but not with parameters of oxygen transportation such as O2 saturation and pO2 values. It 397 
was therefore concluded that there must be other factors such as disturbed sleep or physical stress, 398 
which induce these changes. It was hypothesized that the physiological changes at high altitude 399 
might possibly be influenced or might even be partly under control of the endocrine system.  This 400 
present study does verify this hypothesis due to both the modeling at the level of secretion (and 401 
not concentrations), as well utilizing the study design for pairing.  Moreover, the present results 402 
support and extend the findings of (27) that the concentrations of several hormones, especially 403 
stress related hormones such as cortisol, prolactin and thyroid hormone, change with altitude and 404 
that acclimatization almost normalizes these changes. A side consequence of the present study 405 
reveals that not only the serum hormone concentrations changes with altitude and normalizes with 406 
acclimatization (as shown in (27)) but also the hormone pulse frequency and basal and pulsatile 407 
secretion patterns.   408 
Downloaded from www.physiology.org/journal/ajpendo at Univ Bern Hosp (161.062.252.040) on December 12, 2019.
 
 
  - 19 - 
         Furthermore, this study revealed that endocrine changes are far more complex then described 409 
in (27). The increase of hormone concentrations with altitude seem to be a result of a marked 410 
increase of MPP whereas pulse frequency decreased. This is of relevance as even subtle changes 411 
of MPP and frequency can have marked endocrinological and thereby physiological effects. The 412 
functional effect of pituitary and adrenal hormones is not only due to their serum concentration 413 
but also to their secretion pattern. In women for instance physical and psychological stress and 414 
diseases can reduce the frequency of LH and FSH release, which lead to amenorrhoea even though 415 
total blood concentrations are not substantially affected (20).  416 
       Thus, the observed changes in basal hormone secretion suggest first that endocrine regulation 417 
at high altitude and during acclimatization is far more complex than previously thought and second 418 
that altitude also effects pituitary hormone processing (5, 8). This hypothesis would be consistent 419 
with known suppression of pituitary hormone synthesis by intracellular messengers, such as 420 
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Figure Legends  432 
Figure 1. The concentration profiles are plotted for the eight subjects, for each hormone and each 433 
altitude.  The rows are the five hormones (GH, PROL, Cortisol, TSH, fT4) and the columns are 434 
the four altitudes (450 m, 4800 m, 4800 m Acclimatization, 6050 m).  Within each subplot are the 435 
profiles for the eight subjects delineated by color.  The y-axis scale for each hormone is the same 436 
across altitudes, to enhance comparisons.   437 
 438 
Figure 2.  2a. The recovered secretion rates (mass/distribution volume/min) are plotted for the 439 
eight subjects, for each of the five hormones (rows) and altitudes (columns).    2b. Four key 440 
patterns, across the hormones, that were detected.  Plotted are four statistics that summarize 441 
information about the secretion and kinetic information, as altitudes change.  The four are the 442 
sample means (across 8 subjects) of mass per pulse (MPP), pulse frequency, total secretion and 443 
the fraction of Basal to total secretion.  To place all five hormones on a common plot, for each 444 
hormone, the means are normalized by their maximum (over the four altitudes).   445 
 446 
Figure 3.  Of the ten summary statistics designed to extract distinct structure from the recovered 447 
secretion and elimination rates, the first four (mass per pulse (MPP), pulse frequency, total 448 
secretion and basal secretion) are most fundamental; these are displayed in Figures 3-4.   In 449 
Figures 3a-b, Mass Per Pulse (MPP, 3a) and Pulse Frequency (3b), are plotted. In each 450 
subplot(3a-b), there are two columns.  In the left column are the summary statistic values for the 451 
eight subjects (black asterisk) at each of the four altitudes, for the five hormones (GH, PROL, 452 
Cortisol, TSH, fT4).  The means (dashed line) and medians (solid line) at each altitude, for each 453 
hormone, are linearly connected.  In the right column, the differences in the statistic, for each 454 
Downloaded from www.physiology.org/journal/ajpendo at Univ Bern Hosp (161.062.252.040) on December 12, 2019.
 
 
  - 21 - 
subject, for each hypothesis are calculated and plotted as a function of Hypotheses 1-6.  For 455 
example, in Hypothesis 1, the difference in the values at 4800 m and 4800 m Acclimatization are 456 
calculated.  The means (dashed line) and medians (solid line) are plotted versus Hypotheses 1-6.  457 
A dashed box is drawn around the results for Hypotheses 1-2 to emphasis that they were a priori 458 
formulated-hypotheses of particular importance. 459 
 460 
Figure 4.  In Figures 4a-b are plotted the two summary statistics: total secretion (4a) and basal 461 
secretion (4b). The legend format is the same as in Figure 3, with two columns in each subplot.  462 
That is, in the left column are the summary statistic values for the eight subjects (black asterisk) at 463 
each of the four altitudes, for the five hormones (GH, PROL, Cortisol, TSH, fT4).  The means 464 
(solid line) and medians (dashed line) at each altitude, for each hormone, are linearly connected.  465 
In the right column, the differences in the statistic, for each subject, for each hypothesis are 466 
calculated and plotted as a function of Hypotheses 1-6.   467 
 468 
Figure 5.  5a. For Hypothesis 1-6, and each of the four summary statistics in Figures 3-4: mass 469 
per pulse (MPP), pulse frequency, total secretion and fraction of basal to total secretion, a t-test 470 
was performed and a P-value was calculated for each null hypothesis that there is no change due 471 
to the difference in the two altitudes (e.g., between 4800 m and 450 m).  The P-value is calculated 472 
to each side and the minimum of the two values is the resulting plotted P-value.  If one wishes to 473 
consider two-sided P-values, one would just double the plotted value. What are plotted are the log 474 
P-values versus Hypotheses 1-6, for the five hormones (designated by differing colors) with the 475 
log P-values linearly connected across the hypotheses.  A dashed box is drawn around the results 476 
for Hypotheses 1-2 to emphasis that they were a priori formulated-hypotheses of particular 477 
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importance.  A dashed horizontal line is plotted at log (.05).  For hypotheses that were a priori 478 
formulated for the five hormones, as were Hypotheses 1-2 and the present four summary statistics, 479 
one can argue that comparisons to log (.05) is justified.   5b.  For each hypothesis (1-6), there are 480 
5 hormones and 4 summary statistics (20=4 x 5), and one can consider the multiple comparisons 481 
effect on the log P-values.  For each hypothesis (1-6), a False Discovery Rate (FDR) plot is 482 
presented (at 𝛼 = .05).  There are four symbols (square, x, circle, asterisk) and five colors for the 483 
hormones (Red, Blue, Black, Green, Cyan).  The solid black line denotes the boundary curve for 484 
significance (at 𝛼=.05), assuming no a priori selection of relevant hypotheses.  The red dashed 485 
curve corresponds to the situation where the underlying statistics are correlated;  this curve is given 486 
only for illustrative purposes, since independence is reasonable in the present case: MPP, pulse 487 
frequency, basal secretion and total secretion could all individually go up or down.).  FDR analysis 488 
is presented as a secondary justification for the general results of 5a, where Hypotheses 1-2 and 489 
the present four statistics were formulated a priori to the data.  It can be viewed as supportive 490 
evidence for the results enclosed is the dashed boxes in 5a.  5c. As alternative evidence, a sign test 491 
is now performed and the resulting log P-values are plotted.   A dashed box is drawn around the 492 
results for Hypotheses 1-2 to emphasis that they were a priori formulated-hypotheses of particular 493 
importance.   494 
 495 
Figure 6. Ten summary statistics, designed to extract distinct structure from the recovered 496 
secretion and elimination rates.  In Figures 3-4, four of the summary statistics were plotted.  In 497 
Figure 6, the remaining six summary statistics are presented.  The six statistics are: total pulsatile 498 
secretion (6a), fraction of basal to total secretion (6b), pulse regularity (6c), mode of release (6d), 499 
fast half-life (6e) and slow half-life (6f).   The legend format is the same as in Figures 3-4.  In 500 
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each subplot(4a-f), there are two columns.  In the left column are the summary statistic values for 501 
the eight subjects (black asterisk) at each of the four altitudes, for the five hormones (GH, PROL, 502 
Cortisol, TSH, fT4).  The means (dashed line) and medians (solid line) at each altitude, for each 503 
hormone, are linearly connected.  In the right column, the differences in the statistic, for each 504 
subject, for each hypothesis are calculated and plotted as a function of Hypotheses 1-6.   505 
 506 
Figure 7.  7a. For Hypothesis 1-6, and each of the six summary statistics in Figure 6: total pulsatile 507 
secretion, fraction of basal to total secretion, pulse regularity, mode of release, fast half-life and 508 
slow half-life, a t-test was performed and a P-value was calculated for each null hypothesis.  In 509 
Hypotheses 1-6, the null hypothesis in each, is that there is no change due to the difference in the 510 
two altitudes (e.g., between 4800 m and 450 m).  As in Figure 5, the P-value is calculated to each 511 
side (under the null hypothesis) and the minimum of the two values is the resulting plotted P-value.  512 
What are plotted are the log P-values versus Hypotheses 1-6, for the five hormones (designated by 513 
differing colors) with the log P-values linearly connected across the hypotheses.  A dashed box is 514 
drawn around the results for Hypotheses 1-2 to emphasis that they were a priori formulated-515 
hypotheses of particular importance.  A dashed horizontal line is plotted at log (.05).  For 516 
Hypotheses 1-2, which were a priori formulated for the five hormones, one could (potentially) 517 
argue that comparisons to log (.05) is justified.  This argument is not as strong however as that for 518 
the four summary statistics in Figure 45   7b.  For each hypothesis (1-6), there are 5 hormones and 519 
6 summary statistics (30=6 x 5), and one can consider the multiple comparisons effect on the log 520 
P-values in Figure 7a.  A False Discovery Rate (FDR) plot is presented (at 𝛼 = .05).  There are 521 
six symbols (square, triangle, x, hexagon, circle, asterisk) and five colors for the hormones (Red, 522 
Blue, Black, Green, Cyan).  The dashed curve is for the correlated case and the solid for the 523 
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uncorrelated case, which is appropriate.  Figure 7b is viewed as supportive evidence for the results 524 
enclosed is the dashed boxes in Figure 7a.  7c. As alternative evidence to that Presented in Figure 525 
7a, where a t-test was performed, a sign test is now performed and the resulting log P-values are 526 
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